Page last updated: 2024-08-21

thiazoles and Central Nervous System Neoplasms

thiazoles has been researched along with Central Nervous System Neoplasms in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.88)18.2507
2000's7 (41.18)29.6817
2010's9 (52.94)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raanani, P1
Hino, M; Koh, H; Koh, KR; Kosaka, S; Matsumoto, K; Morita, K; Nakamae, H; Nakane, T; Nishimoto, M; Ohsawa, M1
Brown, RJ; Dhall, G; Eisenstat, D; Finlay, JL; Goldman, S; Osorio, DS1
Banerjee, A; Boyett, JM; Fisher, M; Fouladi, M; Goldman, S; Kun, L; Lulla, R; Onar-Thomas, A; Packer, RJ; Pollack, I; Rood, BR; Smith, C; Stewart, CF; Turner, DC; Wu, S; Young-Pouissant, T1
Arcamone, M; Di Francia, R; Frigeri, F; Luciano, L; Pane, F; Pinto, A1
Ahkavan, D; Bergers, G; Caldwell, JS; Cavenee, WK; Chakravari, A; Chen, Z; Cloughesy, TF; Cvrljevic, A; Dang, J; Dinca, EB; Furnari, FB; Graeber, T; Huang, TT; James, CD; Johns, TG; Lee, FY; Lee, Y; Loo, JA; Lu, KV; Mischel, PS; Nelson, SF; Oderberg, I; Plaisier, SB; Sarkaria, S; Seligson, D; Weinmann, R; Xie, Y; Zhu, S1
Ahluwalia, MS; Battiwalla, M; Cohen, IL; Francis, J; McCarthy, PL; Paplham, P; Smiley, S; Spangenthal, E; Wang, E; Wetzler, M1
Chondropoulos, S; Dervenoulas, J; Economopoulos, T; Economopoulou, C; Ionnidou, ED; Konsioti, F; Papageorgiou, E; Papageorgiou, SG; Pappa, V; Tsirigotis, P; Vasilatou, D1
Fielding, AK1
Cantú-Rodríguez, O; García-Rodríguez, F; Gómez-Almaguer, D; González-Llano, O; Gutiérrez-Aguirre, H; Jaime-Pérez, J1
Cheng, HC; Kuo, HC; Sze, CI; Teng, CC; Wang, TC1
Antolin, I; Herrera, F; Martín, V; Mayo, JC; Rodriguez, C; Sainz, RM1
De Juan, BS; Gelperina, SE; Kreuter, J; Von Briesen, H1
Abdelhalim, A; Barcos, M; Block, AW; Sait, SN; Starostik, P; Wang, ES; Wetzler, M1
Agis, H; Aichberger, KJ; Esterbauer, H; Haas, OA; Herndlhofer, S; Jäger, U; Knöbl, P; Rabitsch, W; Schwarzinger, I; Sillaber, C; Sperr, WR; Thalhammer, R; Valent, P1
Arnan, M; Brethon, B; Brito-Babapulle, F; Dombret, H; Duarte, RF; Eccersley, L; Elonen, E; Gruber, F; Hjorth-Hansen, H; Höglund, M; Klamova, H; Knutsen, H; Koskenvesa, P; Lee, FY; Lundán, T; Luo, R; Mustjoki, S; Paquette, R; Parikh, S; Porkka, K; Raffoux, E; Rimpiläinen, J; Smykla, R; Wild, R; Zwaan, CM1
Coyle, T; Levante, S; Shetler, M; Winfield, J1

Trials

3 trial(s) available for thiazoles and Central Nervous System Neoplasms

ArticleYear
Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:9

    Topics: Adolescent; Central Nervous System Neoplasms; Child; Dasatinib; Female; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrimidines; Retrospective Studies; Thiazoles

2013
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.
    Journal of neuro-oncology, 2015, Volume: 121, Issue:1

    Topics: Adolescent; Antineoplastic Agents; Central Nervous System Neoplasms; Child; Child, Preschool; Female; Humans; Hyponatremia; Imidazoles; Male; Neoplasm Recurrence, Local; Thiazoles; Treatment Outcome; Young Adult

2015
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.
    Blood, 2008, Aug-15, Volume: 112, Issue:4

    Topics: Adolescent; Adult; Aged; Animals; Blood-Brain Barrier; Central Nervous System Neoplasms; Child; Cytogenetic Analysis; Dasatinib; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Monitoring; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Spinal Puncture; Survival Rate; Thiazoles; Treatment Outcome; Tumor Burden

2008

Other Studies

14 other study(ies) available for thiazoles and Central Nervous System Neoplasms

ArticleYear
Taming of the shrew--overcoming extramedullary blast crisis in the era of the new tyrosine kinase inhibitors.
    Acta haematologica, 2013, Volume: 130, Issue:2

    Topics: Antineoplastic Agents; Blast Crisis; Central Nervous System Neoplasms; Dasatinib; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pyrimidines; Thiazoles

2013
Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia.
    Acta haematologica, 2013, Volume: 130, Issue:2

    Topics: Antineoplastic Agents; Blast Crisis; Bone Marrow; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Dasatinib; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Pyrimidines; Radiography; Recurrence; Thiazoles; Transplantation, Homologous; Young Adult

2013
Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome-positive leukemia.
    Blood, 2009, May-14, Volume: 113, Issue:20

    Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Dasatinib; Genes, abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pyrimidines; Recurrence; Thiazoles; Treatment Failure

2009
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
    Cancer research, 2009, Sep-01, Volume: 69, Issue:17

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Movement; Cell Survival; Central Nervous System Neoplasms; Dasatinib; Drug Synergism; Enzyme Activation; ErbB Receptors; Gene Silencing; Glioblastoma; Humans; Mice; Mutation; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fyn; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles

2009
Reversible cardiotoxicity with tyrosine kinase inhibitors.
    Clinical advances in hematology & oncology : H&O, 2010, Volume: 8, Issue:2

    Topics: Adult; Benzamides; Cardiotoxins; Central Nervous System Neoplasms; Dasatinib; Fatal Outcome; Female; Humans; Imatinib Mesylate; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Ventricular Dysfunction, Left

2010
Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression.
    Leukemia research, 2010, Volume: 34, Issue:9

    Topics: Antineoplastic Agents; Benzamides; Central Nervous System Neoplasms; Dasatinib; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Philadelphia Chromosome; Piperazines; Pyrimidines; Remission Induction; Thiazoles

2010
How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Blood, 2010, Nov-04, Volume: 116, Issue:18

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Central Nervous System Neoplasms; Clinical Trials as Topic; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Mutation; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Remission Induction; Thiazoles

2010
Effectiveness of dasatinib in relapsed CNS, Ph+ ALL that is refractory to radiochemotherapy plus imatinib: a case report.
    Clinical advances in hematology & oncology : H&O, 2011, Volume: 9, Issue:11

    Topics: Antineoplastic Agents; Benzamides; Central Nervous System Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dasatinib; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Male; Philadelphia Chromosome; Piperazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Thiazoles; Transplantation, Homologous; Young Adult

2011
The inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK.
    Toxicology and applied pharmacology, 2012, Aug-15, Volume: 263, Issue:1

    Topics: Antineoplastic Agents; Astrocytoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Enzyme Induction; Glioblastoma; Humans; Mitogen-Activated Protein Kinase Kinases; Quinolines; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles

2012
Cytotoxicity and oncostatic activity of the thiazolidinedione derivative CGP 52608 on central nervous system cancer cells.
    Cancer letters, 2004, Jul-28, Volume: 211, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Division; Central Nervous System Neoplasms; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Mice; Oxidative Stress; PC12 Cells; Rats; Thiazoles; Thiosemicarbazones; Tumor Cells, Cultured

2004
Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.
    Journal of drug targeting, 2006, Volume: 14, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Cell Survival; Central Nervous System Neoplasms; Chemistry, Pharmaceutical; Chromatography, Gas; Doxorubicin; Enbucrilate; Excipients; Flow Cytometry; Glioma; L-Lactate Dehydrogenase; Microscopy, Confocal; Nanoparticles; Rats; Tetrazolium Salts; Thiazoles

2006
Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:5

    Topics: Brain; Central Nervous System Neoplasms; Dasatinib; Humans; In Situ Hybridization, Fluorescence; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Remission Induction; Thiazoles; Time Factors; Treatment Outcome

2007
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
    European journal of clinical investigation, 2007, Volume: 37, Issue:10

    Topics: Aged; Antimetabolites, Antineoplastic; Benzamides; Central Nervous System Neoplasms; Cytarabine; Dasatinib; Drug Therapy, Combination; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liposomes; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Outcome

2007
In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.
    Journal of neuro-oncology, 1994, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Central Nervous System Neoplasms; Glioma; Gossypol; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rats; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured

1994